Market by Procedure (Laparoscopy, Orthopedic Surgery, Cardiovascular, Obstetrics and Gynecology, Wound Closure, Plastic & Reconstructive Surgery, Thoracic Surgery, Microvascular, Urology, Neurosurgery, Other Procedures) Type of Infection (Superficial Incisional SSI, Deep Incisional SSI, Organ or Space SSI) Industry Vertical (Hospitals, Ambulatory Surgical Centers) Product (Disinfectants, Manual Reprocessors Solutions, Surgical Drapes, Surgical Gloves, Skin Preparation Solutions, Surgical Irrigation, Surgical Scrubs, Hair Clippers, Medical Nonwovens, Other Products) and Regional Outlook | Forecast 2024-2032
According to Triton Market Research’s report, the Global Surgical Site Infection Control Market is expected to advance with a CAGR of 5.21% over the forecast period 2024-2032.
Report scope can be customized per your requirements - Request Free Sample Report
SURGICAL SITE INFECTION CONTROL MARKET ANALYSIS
The global surgical site infection control market has witnessed significant growth due to the increasing demand for effective infection control measures. Key players include companies specializing in surgical site infection control products and management services. These companies offer solutions such as antiseptics, surgical drapes, sutures, and advanced wound dressings to prevent and treat surgical site infections.
Effective infection control management is essential for reducing the incidence of surgical site wound infections, ensuring patient safety, and maintaining regulatory compliance. Companies are adopting advanced technologies like real-time monitoring, data analytics, and automation to enhance infection control procedures and improve outcomes. Advanced surgical site infection control providers specialize in offering customized solutions tailored to the specific needs of healthcare facilities. These services include infection control procedure optimization, surgical site infection prevention antibiotics, and comprehensive surgical site infection treatment strategies.
SURGICAL SITE INFECTION CONTROL MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES
Escalating Incidence of Hospital-Acquired Infections
The COVID-19 pandemic and other disease outbreaks have underscored the critical role of infection prevention and control (IPC) in healthcare settings. The World Health Organization (WHO) reports that up to 70% of infections can be prevented with good hand hygiene and cost-effective practices. Despite this, the incidence of healthcare-associated infections (HAIs) remains alarmingly high. In acute-care hospitals, seven out of every 100 patients in high-income countries and 15 in low- and middle-income countries acquire at least one HAI during their stay, with 1 in 10 affected patients dying from these infections.
This escalating incidence of HAIs drives the need for advanced infection control measures. The surgical site infection control market is responding with innovative solutions, including surgical site infection control products, SSI prevention antibiotics, and comprehensive management protocols. Key players are focusing on developing and implementing these strategies to reduce infection rates and enhance patient outcomes.
Surge in Medical Waste Due to the use of Disposable Medical Items
The pandemic significantly impacted global health, leading to a surge in medical waste volumes. This increase poses new threats to human and environmental health, as highlighted by a World Health Organization (WHO) report. The extensive use of disposable medical items, such as over 140 million test kits, has generated an estimated 2,600 tons of general waste, primarily plastic, and 731,000 liters of chemical waste. While disposable medical items are crucial for preventing surgical site infections, they also contribute to substantial waste management issues, creating challenges for the studied market. Hence, companies must find a balance between effective infection control and sustainable waste management practices. To address this challenge, companies are exploring environmentally friendly materials, improved waste disposal methods, and efficient recycling processes.
Growth of Minimally Invasive and Outpatient Surgical Practices
Nevertheless, the rise of minimally invasive surgery offers a significant opportunity for the surgical site infection control market. Minimally invasive techniques, such as laparoscopy and robotic surgery, are associated with less pain, shorter hospital stays, and fewer complications than traditional open surgery. These advantages make them increasingly popular among patients and healthcare providers. Laparoscopy, a pioneering form of minimally invasive surgery, uses small incisions, tiny cameras, and surgical tools to perform operations. Robotic surgery, another advanced technique, provides surgeons with an enlarged, 3D view of the surgical site, enhancing precision and control. As minimally invasive and outpatient surgical practices grow, the need for effective surgical site infection control measures becomes crucial.
GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET REPORT SEGMENTATION:
• Market by Procedure:
o Laparoscopy
o Orthopedic Surgery
o Cardiovascular
o Obstetrics and Gynecology
o Wound Closure
o Plastic & Reconstructive Surgery
o Thoracic Surgery
o Microvascular
o Urology
o Neurosurgery
o Other Procedures
• Market by Type of Infection:
o Superficial Incisional SSI
o Deep Incisional SSI
o Organ or Space SSI
• Market by Industry Vertical:
o Hospitals
o Ambulatory Surgical Centers
Hospitals, as the primary centers for surgical
procedures and patient care, have a paramount need for stringent infection
control measures to prevent surgical site infections (SSIs) and ensure patient
safety. Across various departments, including operating rooms, emergency
departments, intensive care units, and patient wards, hospitals implement
comprehensive SSI control protocols. Hospitals invest significantly in a
variety of SSI control products, such as disinfectants, surgical drapes,
gloves, and skin preparation solutions to uphold sterile environments and
reduce SSI incidence during surgical procedures.
• Market by Product:
o Disinfectants
• Skin
Disinfectants
• Hand
Disinfectants
o Manual Reprocessors Solutions
o Surgical Drapes
o Surgical Gloves
o Skin Preparation Solutions
o Surgical Irrigation
o Surgical Scrubs
o Hair Clippers
o Medical Nonwovens
o Other Products
Disinfectants play a crucial role in preventing
surgical site infections (SSIs) by inhibiting the growth of microorganisms on
surfaces, instruments, and skin. They are essential for maintaining a sterile
environment in operating rooms and other healthcare settings. Disinfectants
come in various forms, including sprays, wipes, and solutions, and are
formulated to target specific pathogens commonly associated with SSIs. They are
rigorously tested and regulated to ensure their efficacy and safety in healthcare
settings. Regular use of disinfectants as part of comprehensive infection
control protocols is fundamental in minimizing the risk of SSIs and
safeguarding patient health and well-being.
MARKET BY REGION:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy, the Netherlands and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, Israel, and Rest of Middle East & Africa
KEY SURGICAL SITE INFECTION CONTROL COMPANIES INSIGHTS
The companies’ insights help dive into data about the key players in the surgical site infection control market. The strategic initiatives for each of the companies considered have been covered in detail. Some of the key battery companies’ strategic initiatives are:
Business Divestment & Expansions (June 2023): STERIS Plc and Becton, Dickinson & Company
STERIS Plc entered into a definitive agreement to acquire Becton, Dickinson, and Company’s surgical instrumentation, laparoscopic instrumentation, and sterilization container assets for $540 million.
Product Launch (March 2022): Invenio
Invenio launched its V90 surgical gown series, introducing a fresh line of surgical gowns to the market.
KEY BENEFITS OF THE REPORT:
Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
The scope of the market report comprises the current scenario of the global surgical site infection control market, along with a detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2023-2030.
FAQs:
Q1) What are the major causes of Surgical Site Infections (SSI)?
SSIs can be caused by various factors, including bacterial contamination of the surgical site, compromised patient immune function, inadequate surgical instruments’ sterilization, and poor surgical techniques.
Q2) Who are the major players in the surgical site infection control market?
Major players include Johnson & Johnson, 3M, Becton Dickinson, Stryker, and Getinge are some of the key players in the surgical site infection control market.
Q3) Which years does the surgical site infection control market cover?
Our report explores the historical data of the surgical site infection control market for the years 2020, 2021, 2022, and 2023. Additionally, the report provides a forecast of the market size from 2024 to 2032, with 2023 as the base year.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19
IMPACT
2.2. PORTER’S
FIVE FORCES ANALYSIS
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTES
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. MARKET
MATURITY ANALYSIS
2.4. KEY
MARKET STRATEGIES
2.4.1. PRODUCT
LAUNCHES
2.4.2. ACQUISITIONS
2.4.3. BUSINESS
DIVESTITURES & EXPANSIONS
2.5. MARKET
DRIVERS
2.5.1. ESCALATING
INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.5.2. GROWING
GERIATRIC POPULATION
2.5.3. REGULATORY
GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.6. MARKET
CHALLENGES
2.6.1. INCREASE
IN OUTPATIENT TREATMENT
2.6.2. SURGE
IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.6.3. INSUFFICIENT
AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.7. MARKET
OPPORTUNITIES
2.7.1. GROWTH
OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.7.2. RISE
IN SURGICAL PROCEDURES
2.7.3. TECHNOLOGICAL
ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.8. ANALYST
PERSPECTIVE
3. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC
SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS
AND GYNECOLOGY
3.5. WOUND
CLOSURE
3.6. PLASTIC
& RECONSTRUCTIVE SURGERY
3.7. THORACIC
SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER
PROCEDURES
4. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL
INCISIONAL SSI
4.2. DEEP
INCISIONAL SSI
4.3. ORGAN
OR SPACE SSI
5. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY
SURGICAL CENTERS
6. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN
DISINFECTANTS
6.1.2. HAND
DISINFECTANTS
6.2. MANUAL
REPROCESSORS SOLUTIONS
6.3. SURGICAL
DRAPES
6.4. SURGICAL
GLOVES
6.5. SKIN
PREPARATION SOLUTIONS
6.6. SURGICAL
IRRIGATION
6.7. SURGICAL
SCRUBS
6.8. HAIR
CLIPPERS
6.9. MEDICAL
NONWOVENS
6.10. OTHER
PRODUCTS
7. GLOBAL
SURGICAL SITE INFECTION CONTROL MARKET – BY REGIONAL OUTLOOK
7.1. NORTH
AMERICA
7.1.1. MARKET
BY PROCEDURE
7.1.2. MARKET
BY TYPE OF INFECTION
7.1.3. MARKET
BY INDUSTRY VERTICAL
7.1.4. MARKET
BY PRODUCT
7.1.5. COUNTRY
ANALYSIS
7.1.5.1. UNITED
STATES
7.1.5.1.1. UNITED
STATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET
BY PROCEDURE
7.2.2. MARKET
BY TYPE OF INFECTION
7.2.3. MARKET
BY INDUSTRY VERTICAL
7.2.4. MARKET
BY PRODUCT
7.2.5. COUNTRY
ANALYSIS
7.2.5.1. UNITED
KINGDOM
7.2.5.1.1. UNITED
KINGDOM SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.2. GERMANY
7.2.5.2.1. GERMANY
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.4. SPAIN
7.2.5.4.1. SPAIN SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.5. ITALY
7.2.5.5.1. ITALY SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.6. THE NETHERLANDS
7.2.5.6.1. THE NETHERLANDS
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.7. REST
OF EUROPE
7.2.5.7.1. REST
OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET
BY PROCEDURE
7.3.2. MARKET
BY TYPE OF INFECTION
7.3.3. MARKET
BY INDUSTRY VERTICAL
7.3.4. MARKET
BY PRODUCT
7.3.5. COUNTRY
ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA SURGICAL
SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.4. SOUTH
KOREA
7.3.5.4.1. SOUTH
KOREA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.5. ASEAN
COUNTRIES
7.3.5.5.1. ASEAN
COUNTRIES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.6. AUSTRALIA
& NEW ZEALAND
7.3.5.6.1. AUSTRALIA
& NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET FORECAST &
PROSPECTS
7.3.5.7. REST
OF ASIA-PACIFIC
7.3.5.7.1. REST
OF ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET FORECAST &
PROSPECTS
7.4. LATIN
AMERICA
7.4.1. MARKET
BY PROCEDURE
7.4.2. MARKET
BY TYPE OF INFECTION
7.4.3. MARKET
BY INDUSTRY VERTICAL
7.4.4. MARKET
BY PRODUCT
7.4.5. COUNTRY
ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.4.5.3. REST
OF LATIN AMERICA
7.4.5.3.1. REST
OF LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST &
PROSPECTS
7.5. MIDDLE
EAST AND AFRICA
7.5.1. MARKET
BY PROCEDURE
7.5.2. MARKET
BY TYPE OF INFECTION
7.5.3. MARKET
BY INDUSTRY VERTICAL
7.5.4. MARKET
BY PRODUCT
7.5.5. COUNTRY
ANALYSIS
7.5.5.1. UNITED
ARAB EMIRATES
7.5.5.1.1. UNITED
ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST &
PROSPECTS
7.5.5.2. SAUDI
ARABIA
7.5.5.2.1. SAUDI
ARABIA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.3. TURKEY
7.5.5.3.1. TURKEY
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH
AFRICA
7.5.5.4.1. SOUTH
AFRICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.5. ISRAEL
7.5.5.5.1. ISRAEL
SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.6. REST
OF MIDDLE EAST & AFRICA
7.5.5.6.1. REST
OF MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST
& PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. AMERICAN
POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY
STRENGTHS
8.2.4. KEY
CHALLENGES
8.3. ANSELL
LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. BELIMED
LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. BECTON,
DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. BIOMERIEUX
SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. GETINGE
AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. GAMA
HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. JOHNSON
& JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY
STRENGTHS
8.9.4. KEY
CHALLENGES
8.10. SOTERA
HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY
STRENGTHS
8.10.4. KEY
CHALLENGES
8.11. KIMBERLY-CLARK
CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY
STRENGTHS
8.11.4. KEY
CHALLENGES
8.12. STERIS
CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. STRYKER
CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN
$ MILLION)
TABLE 2: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $
MILLION)
TABLE 3: LIST OF PRODUCT
LAUNCHES
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF BUSINESS
DIVESTITURES & EXPANSIONS
TABLE 6: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 7: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 11: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN
$ MILLION)
TABLE 12: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $
MILLION)
TABLE 13: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE 14: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 15: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $
MILLION)
TABLE 16: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE 17: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $
MILLION)
TABLE 18: NORTH AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $
MILLION)
TABLE 19: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 20: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 21: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 22: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 23: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 24: EUROPE SURGICAL SITE
INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE 26: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $
MILLION)
TABLE 28: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE 29: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC
SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $
MILLION)
TABLE 31: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE 32: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 33: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $
MILLION)
TABLE 34: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE 35: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $
MILLION)
TABLE 36: LATIN AMERICA
SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $
MILLION)
TABLE 37: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032
(IN $ MILLION)
TABLE 38: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $
MILLION)
TABLE 39: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032
(IN $ MILLION)
TABLE 40: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032
(IN $ MILLION)
TABLE 41: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $
MILLION)
TABLE 42: MIDDLE EAST AND
AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN
$ MILLION)
FIGURE 1: PORTER’S FIVE FORCES
ANALYSIS
FIGURE 2: MARKET MATURITY
ANALYSIS
FIGURE 3: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 4: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 5: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 6: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $
MILLION)
FIGURE 8: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL SURGICAL SITE
INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032
(IN $ MILLION)
FIGURE 10: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $
MILLION)
FIGURE 15: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032 (IN %)
FIGURE 16: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $
MILLION)
FIGURE 17: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 20: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $
MILLION)
FIGURE 22: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 23: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 24: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN %)
FIGURE 25: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 26: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 27: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN
$ MILLION)
FIGURE 28: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 29: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 30: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $
MILLION)
FIGURE 31: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 32: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 33: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 34: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 35: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 36: GLOBAL SURGICAL
SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 37: UNITED STATES
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: CANADA SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: UNITED KINGDOM
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: GERMANY SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: FRANCE SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: ITALY SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 43: SPAIN SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 44: THE NETHERLANDS
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 45: REST OF EUROPE
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 46: CHINA SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 47: JAPAN SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 48: INDIA SURGICAL SITE
INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 49: SOUTH KOREA
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 50: ASEAN COUNTRIES
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 51: AUSTRALIA & NEW
ZEALAND SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 52: REST OF
ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 53: BRAZIL SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 54: MEXICO SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 55: REST OF LATIN
AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 56: UNITED ARAB
EMIRATES SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 57: SAUDI ARABIA
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 58: TURKEY SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 59: SOUTH AFRICA
SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 60: ISRAEL SURGICAL
SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 61: REST OF MIDDLE EAST
& AFRICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)